
Sign up to save your podcasts
Or


Dr. Jeff Ratliff talks with Drs. Howard Colman and Kelly Fritz about the availability of lomustine for the treatment of glioblastoma multiforme (GBM) in light of the drug's recent withdrawal from Medicare Part D coverage.
By American Academy of Neurology4.7
283283 ratings
Dr. Jeff Ratliff talks with Drs. Howard Colman and Kelly Fritz about the availability of lomustine for the treatment of glioblastoma multiforme (GBM) in light of the drug's recent withdrawal from Medicare Part D coverage.

320 Listeners

497 Listeners

51 Listeners

288 Listeners

3,337 Listeners

13 Listeners

1,154 Listeners

22 Listeners

194 Listeners

361 Listeners

513 Listeners

133 Listeners

181 Listeners

370 Listeners

79 Listeners